TMCnet News
SELLAS Life Sciences to Participate in the Cantor Fitzgerald Global Healthcare ConferenceNEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, and members of the SELLAS management team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference, taking place in New York, NY, from September 26-28, 2023. Format: Panel presentation and one-on-one investor meetings For more information about the conference, please refer to the conference website or contact your Cantor Fitzgerald representative directly. About SELLAS Life Sciences Group, Inc. Investor Contact ![]() |